Detalles de la búsqueda
1.
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥â¯60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023.
Euro Surveill
; 29(3)2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38240061
2.
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
Euro Surveill
; 29(13)2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38551095
3.
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.
Euro Surveill
; 29(8)2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38390651
4.
Ongoing measles outbreaks in Romania, March 2023 to August 2023.
Euro Surveill
; 28(35)2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650907
5.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Euro Surveill
; 28(47)2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37997666
6.
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.
Euro Surveill
; 27(21)2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35620997
7.
CO2 Hydrogenation Catalyzed by Graphene-Based Materials.
Molecules
; 27(11)2022 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35684305
8.
Fatal Form of COVID-19 in a Young Male Bodybuilder Anabolic Steroid Using: The First Autopsied Case.
Medicina (Kaunas)
; 58(10)2022 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36295534
9.
Pt/UiO-66 Nanocomposites as Catalysts for CO2 Methanation Process.
J Nanosci Nanotechnol
; 19(6): 3187-3196, 2019 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30744742
10.
Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania.
Euro Surveill
; 24(29)2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31339098
11.
Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort.
Euro Surveill
; 24(48)2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31796152
12.
Neurologic Complications of Influenza B Virus Infection in Adults, Romania.
Emerg Infect Dis
; 23(4): 574-581, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28322689
13.
Graphene-bimetallic nanoparticle composites with enhanced electro-catalytic detection of bisphenol A.
Nanotechnology
; 27(48): 484001, 2016 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27804923
14.
Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Euro Surveill
; 21(7): pii=30139, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26924024
15.
Epidemiological and molecular investigation of a rubella outbreak, Romania, 2011 to 2012.
Euro Surveill
; 21(38)2016 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27684329
16.
Differentiation of influenza B lineages from clinical samples by one-step real-time RT-PCR.
Roum Arch Microbiol Immunol
; 73(1-2): 25-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25518567
17.
Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022-23 VEBIS multicentre study in Europe.
Vaccine
; 42(16): 3547-3554, 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38704257
18.
Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023-January 2024.
Vaccine
; 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38839521
19.
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
Influenza Other Respir Viruses
; 18(2): e13255, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38403302
20.
Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.
Influenza Other Respir Viruses
; 18(1): e13243, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38204584